PharmaSeek
WCG is a global leader in accelerating clinical research by providing solutions that improve quality, efficiency, and safety. With over 55 years of experience, WCG connects sponsors, CROs, sites, and participants through expertise, data, and technology to deliver impactful therapies faster while maintaining high standards of human subject protection. WCG is committed to empowering research institutions with innovative technology solutions, including the integration of platforms like Velos eResearch, to streamline clinical trial management and enhance research productivity.
Industries
Nr. of Employees
Very Large (1000+)
Products
Study timeline optimization solution
A solution combining feasibility, site selection and recruitment analytics to reduce study timelines through data-driven site matching and real-time performance monitoring.
Enterprise CTMS and study build solution
Enterprise CTMS platform and study-build services to centralize administrative, financial and regulatory components of clinical research; links study status, enrollment, calendars, budgets, billing and EDC to improve institutional research management.
IRB document management and eTMF integration
Document portal integration that automatically transfers IRB documents and associated metadata into electronic TMF platforms to maintain inspection-ready master files.
Compliance and research oversight platform
Web-based compliance and research oversight solution for institutions to manage IRB submissions, site-specific smart forms, and collaborative workflows for human subjects, animal and recombinant DNA research.
Clinical trial listing and patient-facing trial identification service
Public-facing clinical trial listing service that helps patients identify trial opportunities and supports sponsor listing visibility.
Study timeline optimization solution
A solution combining feasibility, site selection and recruitment analytics to reduce study timelines through data-driven site matching and real-time performance monitoring.
Enterprise CTMS and study build solution
Enterprise CTMS platform and study-build services to centralize administrative, financial and regulatory components of clinical research; links study status, enrollment, calendars, budgets, billing and EDC to improve institutional research management.
IRB document management and eTMF integration
Document portal integration that automatically transfers IRB documents and associated metadata into electronic TMF platforms to maintain inspection-ready master files.
Compliance and research oversight platform
Web-based compliance and research oversight solution for institutions to manage IRB submissions, site-specific smart forms, and collaborative workflows for human subjects, animal and recombinant DNA research.
Clinical trial listing and patient-facing trial identification service
Public-facing clinical trial listing service that helps patients identify trial opportunities and supports sponsor listing visibility.
Services
Independent ethical review, single-IRB solutions for multi-site trials, and IRB document management oversight to accelerate site activation and ensure participant protections.
Administration of convened IBC meetings, biosafety protocol review for gene transfer and recombinant DNA research, and Pre-RAC/NIH biosafety support.
End-to-end safety services including adverse event processing, aggregate reporting, medical review, risk management and operational staffing to support clinical and marketed products.
Tailored recruitment campaigns, on-site enrollment support, chart review, local outreach and partnerships with patient communities to accelerate enrollment and improve retention.
Operational management of independent committees with access to medical, statistical and safety experts to adjudicate endpoints and monitor trial safety.
Enterprise CTMS deployment and study build support that links study status, patient enrollment, calendars, budgets, billing and EDC; includes platform configuration, integration, and operational support for institutions.
Independent ethical review, single-IRB solutions for multi-site trials, and IRB document management oversight to accelerate site activation and ensure participant protections.
Administration of convened IBC meetings, biosafety protocol review for gene transfer and recombinant DNA research, and Pre-RAC/NIH biosafety support.
End-to-end safety services including adverse event processing, aggregate reporting, medical review, risk management and operational staffing to support clinical and marketed products.
Tailored recruitment campaigns, on-site enrollment support, chart review, local outreach and partnerships with patient communities to accelerate enrollment and improve retention.
Operational management of independent committees with access to medical, statistical and safety experts to adjudicate endpoints and monitor trial safety.
Enterprise CTMS deployment and study build support that links study status, patient enrollment, calendars, budgets, billing and EDC; includes platform configuration, integration, and operational support for institutions.
Expertise Areas
- Ethical review and biosafety oversight
- Clinical trial operations and site enablement
- Patient recruitment and retention strategies
- Pharmacovigilance and safety operations
Key Technologies
- Clinical trial management systems (CTMS)
- Electronic trial master file (eTMF) integration
- Electronic data capture (EDC)
- Electronic clinical outcome assessment (eCOA) / ePRO platforms
News & Updates
Enrollment closed nearly 3 months ahead of schedule, with media outreach under budget and site document review suggestions.
WCG’s IBC Services has administered over 4,000 convened IBC meetings globally since 2001, including reviews for human gene transfer trials.
WCG acquired Vigilare, a top provider of pharmacovigilance and drug safety solutions, to enhance its offerings in safety and regulatory compliance.
WCG partnered with Veeva to connect its MyConnexus IRB portal with Veeva Vault eTMF for faster, error-free document transfer.
WCG acquired KMR Group and Metrics Champion Consortium to provide benchmarking and analytics for clinical research performance.
WCG opened a new office in Tokyo to support complex, global clinical trials, especially in oncology and CNS.
Enrollment closed nearly 3 months ahead of schedule, with media outreach under budget and site document review suggestions.
WCG’s IBC Services has administered over 4,000 convened IBC meetings globally since 2001, including reviews for human gene transfer trials.
WCG acquired Vigilare, a top provider of pharmacovigilance and drug safety solutions, to enhance its offerings in safety and regulatory compliance.
WCG partnered with Veeva to connect its MyConnexus IRB portal with Veeva Vault eTMF for faster, error-free document transfer.
WCG acquired KMR Group and Metrics Champion Consortium to provide benchmarking and analytics for clinical research performance.
WCG opened a new office in Tokyo to support complex, global clinical trials, especially in oncology and CNS.